{"id":4422,"date":"2019-03-26T06:10:52","date_gmt":"2019-03-26T06:10:52","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?post_type=study_trials&#038;p=4422"},"modified":"2019-03-26T06:10:52","modified_gmt":"2019-03-26T06:10:52","slug":"%e0%a4%85%e0%a4%82%e0%a4%a4%e0%a4%b0%e0%a5%8d%e0%a4%b0%e0%a4%be%e0%a4%b7%e0%a5%8d%e0%a4%9f%e0%a5%8d%e0%a4%b0%e0%a5%80%e0%a4%af-%e0%a4%a6%e0%a5%81%e0%a4%b0%e0%a5%8d%e0%a4%b2%e0%a4%ad-%e0%a4%b9%e0%a4%bf","status":"publish","type":"study_trials","link":"https:\/\/www.erdheim-chester.org\/hi\/study_trials\/international-rare-histiocytic-disorders-registry-irhdr\/","title":{"rendered":"\u0905\u0902\u0924\u0930\u094d\u0930\u093e\u0937\u094d\u091f\u094d\u0930\u0940\u092f \u0926\u0941\u0930\u094d\u0932\u092d \u0939\u093f\u0938\u094d\u091f\u093f\u092f\u094b\u0938\u093e\u0907\u091f\u093f\u0915 \u0935\u093f\u0915\u093e\u0930 \u0930\u091c\u093f\u0938\u094d\u091f\u094d\u0930\u0940 (IRHDR)"},"content":{"rendered":"<p><strong>\u0905\u0927\u094d\u092f\u092f\u0928 \u0915\u093e \u0909\u0926\u094d\u0926\u0947\u0936\u094d\u092f:&nbsp;<\/strong> \u090f\u0915 \u0905\u0902\u0924\u0930\u094d\u0930\u093e\u0937\u094d\u091f\u094d\u0930\u0940\u092f \u0926\u0941\u0930\u094d\u0932\u092d \u0939\u093f\u0938\u094d\u091f\u093f\u092f\u094b\u0938\u093e\u0907\u091f\u093f\u0915 \u0935\u093f\u0915\u093e\u0930\u094b\u0902 \u0930\u091c\u093f\u0938\u094d\u091f\u094d\u0930\u0940 (IRHDR) \u0915\u0940 \u0938\u094d\u0925\u093e\u092a\u0928\u093e RHDs \u0915\u0947 \u090f\u0915 \u0938\u092e\u093e\u0928 \u0928\u093f\u0926\u093e\u0928 \u0915\u0947 \u0938\u093e\u0925-\u0938\u093e\u0925 RHD \u0935\u093e\u0932\u0947 \u0930\u094b\u0917\u093f\u092f\u094b\u0902 \u0915\u0947 \u0928\u0948\u0926\u093e\u0928\u093f\u0915, \u092e\u0939\u093e\u092e\u093e\u0930\u0940 \u0935\u093f\u091c\u094d\u091e\u093e\u0928 \u0938\u0902\u092c\u0902\u0927\u0940, \u0909\u092a\u091a\u093e\u0930 \u0914\u0930 \u0909\u0924\u094d\u0924\u0930\u091c\u0940\u0935\u093f\u0924\u093e \u0921\u0947\u091f\u093e \u0915\u0947 \u0938\u0902\u0917\u094d\u0930\u0939 \u0914\u0930 \u0935\u093f\u0936\u094d\u0932\u0947\u0937\u0923 \u0915\u094b \u0938\u0941\u0917\u092e \u092c\u0928\u093e\u090f\u0917\u0940\u0964 \u092f\u0939 \u0930\u091c\u093f\u0938\u094d\u091f\u094d\u0930\u0940 \u0935\u093f\u0936\u0947\u0937\u091c\u094d\u091e \u092a\u0948\u0925\u094b\u0932\u0949\u091c\u0940 \u0938\u092e\u0940\u0915\u094d\u0937\u093e\u090f\u0902 \u092d\u0940 \u092a\u094d\u0930\u0926\u093e\u0928 \u0915\u0930\u0947\u0917\u0940 \u0914\u0930 \u092d\u0935\u093f\u0937\u094d\u092f \u092e\u0947\u0902 \u091a\u093f\u0915\u093f\u0924\u094d\u0938\u0940\u092f \u0938\u093f\u092b\u093e\u0930\u093f\u0936\u094b\u0902 \u0915\u093e \u092e\u093e\u0930\u094d\u0917 \u092a\u094d\u0930\u0936\u0938\u094d\u0924 \u0915\u0930 \u0938\u0915\u0924\u0940 \u0939\u0948\u0964\u00a0 \u0907\u0938\u0915\u0947 \u0905\u0932\u093e\u0935\u093e, IRHDR \u092d\u0935\u093f\u0937\u094d\u092f \u0915\u0947 \u0928\u0948\u0926\u093e\u0928\u093f\u0915 \u092a\u0930\u0940\u0915\u094d\u0937\u0923\u094b\u0902 \u0915\u0947 \u0932\u093f\u090f \u090f\u0915 \u0930\u0942\u092a\u0930\u0947\u0916\u093e \u092a\u094d\u0930\u0926\u093e\u0928 \u0915\u0930 \u0938\u0915\u0924\u093e \u0939\u0948, \u091c\u093f\u0938\u0938\u0947 \u0909\u0924\u094d\u0915\u0943\u0937\u094d\u091f \u0905\u0928\u0941\u0938\u0902\u0927\u093e\u0928 \u0905\u0935\u0938\u0930 \u0938\u0943\u091c\u093f\u0924 \u0939\u094b\u0902\u0917\u0947\u0964 \u0905\u0902\u0924 \u092e\u0947\u0902, IRHDR \u0915\u0947 \u092e\u093e\u0927\u094d\u092f\u092e \u0938\u0947 \u092d\u0935\u093f\u0937\u094d\u092f \u092e\u0947\u0902 \u0928\u0948\u0926\u093e\u0928\u093f\u0915 \u0921\u0947\u091f\u093e \u0914\u0930 \u0938\u093e\u0925\u0940 \u091c\u0940\u0935\u0935\u093f\u091c\u094d\u091e\u093e\u0928 \u0905\u0927\u094d\u092f\u092f\u0928\u094b\u0902 \u0915\u0947 \u092c\u0940\u091a \u090f\u0915 \u092a\u0939\u091a\u093e\u0928-\u0930\u0939\u093f\u0924 \u0932\u093f\u0902\u0915 \u0938\u0902\u092d\u093e\u0935\u093f\u0924 \u0930\u0942\u092a \u0938\u0947 \u0938\u094d\u0925\u093e\u092a\u093f\u0924 \u0915\u093f\u092f\u093e \u091c\u093e \u0938\u0915\u0924\u093e \u0939\u0948\u0964 \u092f\u0939 \u0907\u0928 \u0926\u0941\u0930\u094d\u0932\u092d \u0930\u094b\u0917\u094b\u0902 \u0915\u0947 \u0915\u093e\u0930\u0923\u094b\u0902 \u0915\u094b \u0938\u092e\u091d\u0928\u0947 \u0924\u0925\u093e \u0938\u0902\u092d\u093e\u0935\u093f\u0924 \u091a\u093f\u0915\u093f\u0924\u094d\u0938\u0940\u092f \u0932\u0915\u094d\u0937\u094d\u092f\u094b\u0902 \u0915\u0940 \u092a\u0939\u091a\u093e\u0928 \u0915\u0930\u0928\u0947 \u092e\u0947\u0902 \u0914\u0930 \u0938\u0939\u093e\u092f\u0924\u093e \u0915\u0930 \u0938\u0915\u0924\u093e \u0939\u0948\u0964.<\/p>\n<p><strong>\u092a\u094d\u0930\u092e\u0941\u0916 \u0905\u0928\u094d\u0935\u0947\u0937\u0915:<\/strong>&nbsp; \u0909\u0938\u094d\u0938\u093e\u092e\u093e \u0905\u092c\u094d\u0932\u093e, \u090f\u092e\u0921\u0940, 416-813-7879, oussama.abla@sickkids.ca \u2013 \u092f\u093e \u2013 \u092a\u094d\u0930\u0947\u0930\u0923\u093e \u091a\u094b\u092a\u0921\u093c\u093e, 416-813-7654 \u090f\u0915\u094d\u0938\u091f\u0947\u0902\u0936\u0928 202043, prerna.chopra@sickkids.ca<\/p>\n<p><strong>\u0905\u0928\u0941\u0930\u094b\u0927\u093f\u0924 \u0930\u094b\u0917\u0940 \u0938\u0939\u092d\u093e\u0917\u093f\u0924\u093e:<\/strong>&nbsp; \u0915\u094b\u0908 \u092d\u0940 \u0930\u094b\u0917\u0940 \u091c\u093f\u0938\u0947 ECD \u0915\u093e \u0928\u093f\u0926\u093e\u0928 \u0915\u093f\u092f\u093e \u0917\u092f\u093e \u0939\u094b (\u091c\u0940\u0935\u093f\u0924 \u092f\u093e \u092e\u0943\u0924) \u0907\u0938 \u092a\u0930\u0940\u0915\u094d\u0937\u0923 \u092e\u0947\u0902 \u0936\u093e\u092e\u093f\u0932 \u0915\u093f\u092f\u093e \u091c\u093e \u0938\u0915\u0924\u093e \u0939\u0948 \u092f\u0926\u093f \u0915\u0947\u0902\u0926\u094d\u0930\u0940\u092f \u0938\u092e\u0940\u0915\u094d\u0937\u093e \u0915\u0947 \u0932\u093f\u090f \u0909\u092a\u092f\u0941\u0915\u094d\u0924 \u092a\u0948\u0925\u094b\u0932\u0949\u091c\u0940 \u0928\u092e\u0942\u0928\u093e \u0909\u092a\u0932\u092c\u094d\u0927 \u0939\u094b\u0964.<\/p>\n<p><strong>ClinicalTrials.gov \u092a\u0939\u091a\u093e\u0928\u0915\u0930\u094d\u0924\u093e:<\/strong> \u090f\u0928\u0938\u0940\u091f\u094002285582<\/p>","protected":false},"excerpt":{"rendered":"<p>Study Objective:&nbsp; The creation of an International Rare Histiocytic Disorders Registry (IRHDR) will facilitate a uniform diagnosis of the RHD\u2019s, as well as the collection and analysis of the clinical, [&hellip;]<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_study_trials_cat":0,"_links_to":"","_links_to_target":""},"study_trials_cat":[35],"class_list":["post-4422","study_trials","type-study_trials","status-publish","hentry","study_trials_cat-registry"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/study_trials\/4422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/study_trials"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/types\/study_trials"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/media?parent=4422"}],"wp:term":[{"taxonomy":"study_trials_cat","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/study_trials_cat?post=4422"}],"curies":[{"name":"\u0921\u092c\u094d\u0932\u094d\u092f\u0942\u092a\u0940","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}